Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.2 (
focal adhesion kinase
)
44,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Raf Kinase Inhibitor Protein (RKIP) has been extensively reported as an inhibitor of key signaling pathways involved in the aggressive tumor phenotype and shows decreased expression in several types of cancers. However, little is known about RKIP in melanoma or regarding its function in normal cells. We examined the role of RKIP in both primary melanocytes and malignant melanoma cells and evaluated its diagnostic and prognostic value. IHC analysis revealed a significantly higher expression of RKIP in nevi compared with early-stage (stage I-II, AJCC 8th) melanoma biopsies. Proliferation, wound healing, and collagen-coated transwell assays uncovered the implication of RKIP on the motility but not on the proliferative capacity of melanoma cells as RKIP protein levels were inversely correlated with the migration capacity of both primary and metastatic melanoma cells but did not alter other parameters. As shown by RNA sequencing, endogenous RKIP knockdown in primary melanocytes triggered the deregulation of cellular differentiation-related processes, including genes (i.e., ZEB1, THY-1) closely related to the
EMT
. Interestingly, NANOG was identified as a putative
transcriptional regulator
of many of the deregulated genes, and RKIP was able to decrease the activation of the NANOG promoter. As a whole, our data support the utility of RKIP as a diagnostic marker for early-stage melanomas. In addition, these findings indicate its participation in the maintenance of a differentiated state of melanocytic cells by modulating genes intimately linked to the cellular motility and explain the progressive decrease of RKIP often described in tumors.
...
PMID:RKIP Regulates Differentiation-Related Features in Melanocytic Cells. 3250 39
Syringate and vanillate are the major metabolites of lignin biodegradation. In
Sphingobium
sp. strain
SYK
-6, syringate is O demethylated to gallate by consecutive reactions catalyzed by DesA and LigM, and vanillate is O demethylated to protocatechuate by a reaction catalyzed by LigM. The gallate ring is cleaved by DesB, and protocatechuate is catabolized via the protocatechuate 4,5-cleavage pathway. The transcriptions of
desA
,
ligM
, and
desB
are induced by syringate and vanillate, while those of
ligM
and
desB
are negatively regulated by the MarR-type
transcriptional regulator
DesR, which is not involved in
desA
regulation. Here, we clarified the regulatory system for
desA
transcription by analyzing the IclR-type
transcriptional regulator
desX
, located downstream of
desA
Quantitative reverse transcription (RT)-PCR analyses of a
desX
mutant indicated that the transcription of
desA
was negatively regulated by DesX. In contrast, DesX was not involved in the regulation of
ligM
and
desB
The ferulate catabolism genes (
ferBA
), under the control of a MarR-type
transcriptional regulator
, FerC, are located upstream of
desA
RT-PCR analyses suggested that the
ferB-ferA
-SLG_25010-
desA
gene cluster consists of the
ferBA
operon and the SLG_25010-
desA
operon. Promoter assays revealed that a syringate- and vanillate-inducible promoter is located upstream of SLG_25010. Purified DesX bound to this promoter region, which overlaps an 18-bp inverted-repeat sequence that appears to be essential for the DNA binding of DesX. Syringate and vanillate inhibited the DNA binding of DesX, indicating that the compounds are effector molecules of DesX.
IMPORTANCE
Syringate is a major degradation product in the microbial and chemical degradation of syringyl lignin. Along with other low-molecular-weight aromatic compounds, syringate is produced by chemical lignin depolymerization. Converting this mixture into value-added chemicals using bacterial metabolism (i.e., biological funneling) is a promising option for lignin valorization. To construct an efficient microbial lignin conversion system, it is necessary to identify and characterize the genes involved in the uptake and catabolism of lignin-derived aromatic compounds and to elucidate their transcriptional regulation. In this study, we found that the transcription of
desA
, encoding syringate
O
-demethylase in
SYK
-6, is regulated by an IclR-type
transcriptional regulator
, DesX. The findings of this study, combined with our previous results on
desR
(encoding a MarR
transcriptional regulator
that controls the transcription of
ligM
and
desB
), provide an overall picture of the transcriptional-regulatory systems for syringate and vanillate catabolism in
SYK
-6.
...
PMID:The Syringate
O
-Demethylase Gene of
Sphingobium
sp. Strain SYK-6 Is Regulated by DesX, while Other Vanillate and Syringate Catabolism Genes Are Regulated by DesR. 3291 54
<< Previous
1
2
3
4
5